Skip to main content

Table 4 Description of MACE

From: Evaluation of therapy management and outcome in Takotsubo syndrome

Kaplan-Meier estimation
   estimated rate (95%-confidence interval)  
MACE   24 months 36 months
Total events 9 (12%) 12.5 (6.4–23.5) 15.3 (8.0–28.0)
Death 4 (5.6%) 4.6 (1.5–13.5) 7.6 (2.8–20.3)
Stroke 3 (4.2%) 4.9 (1.6–14.7) 4.9 (1.6–14.7)
MI/TTS 2 (2.8%) 3.5 (0.9–13.6) 3.5 (0.9–13.6)
  1. Data is presented as number of patients and percentage. Estimated event rates are presented with Kaplan-Meier estimation after 24 and 36 months
  2. MACE major adverse clinical events, MI myocardial infarction, TTS Takotsubo syndrome